Rick Doblin, Ph.D., of MAPS (@RickDoblin) / X

Rick Doblin, Ph.D., of MAPS

859 posts

Rick Doblin, Ph.D., of MAPS

@RickDoblin

Founder and President of the Multidisciplinary Association for Psychedelic Studies (@MAPS) • Account managed by @MAPS

Boston, Massachusetts

Joined February 2010

Rick Doblin, Ph.D., of MAPS
@RickDoblin
Dec 17, 2020
It’s with an enormous sense of pride, satisfaction, and relief that I can share that @MAPS learned that the first of two Phase 3 studies of MDMA-assisted psychotherapy for PTSD was statistically significant and is considered a successful Phase 3 study: maps.org/20201217a
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Apr 8, 2021
35 years ago today, I founded the Multidisciplinary Association for Psychedelic Studies (@MAPS). Happy 35th anniversary, MAPS!
Rick Doblin, Ph.D., of MAPS
@RickDoblin
May 10, 2021
Some days I wake up and can’t believe how far we’ve come. Today, @MAPS is featured on the front page of The New York Times (@NYTimes)! maps.org/20210510a
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Jul 9, 2019
I am thrilled to announce that the recording of my Ted Talk about psychedelic research is now available! On the main stage at TED2019, I spoke on how psychedelics can shift the field of mental health and MAPS’ MDMA-assisted psychotherapy research. go.ted.com/rickdoblin
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Mar 31, 2023
My 4th appearance on the @joerogan Experience was just released—check it out! #JRE Thanks to Joe for hosting me and bringing visibility to @MAPS at such a critical moment in the #psychedelic movement. open.spotify.com/episode/1EMSI2…
44K
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Nov 26, 2021
Today, The @guardian published my op-ed outlining why @MAPS envisions a day when psychedelics will be more than a last-ditch treatment: they will be a catalyst for mass mental health.
Psychedelics can change humanity for the better. It’s time to unlock their power | Rick Doblin
From theguardian.com
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Aug 5, 2022
100,000 is a very large number of therapists, but considering the millions of people with PTSD and depression, it’s not unreasonable. @MAPS aims to train 25,000 therapists in MDMA-assisted therapy for PTSD by 2030. @LAWeekly @Berkeley_Psyche @MichaelPollan
The Need for 100,000 Psychedelic Facilitators is Real - LA Weekly
From laweekly.com
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Nov 5, 2020
We are delighted to see legal access to psychedelics for spiritual, health, or personal growth join cannabis reform as a popular and bipartisan issue despite the barriers imposed by antiquated drug policies.
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Nov 5, 2021
If we do succeed with our second Phase 3 study of MDMA-assisted therapy for PTSD, the whole field of psychedelic psychotherapy will have been proven in one instance, serving as the pathbreaker with the FDA. @MAPS @TODAYshow @nbc @SavannahGuthrie @jonlubecky
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Nov 4, 2021
Paired with his audacious dedication to humanizing people who use drugs, @DrCarlHart challenges the fear-based dogmas of the War on Drugs. Welcome to the @MAPS Board of Directors, Carl!
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Aug 27, 2017
It’s my pleasure to share the most important research update that has ever taken place in @MAPS’ 31-year history: maps.org/breakthrough
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Oct 2, 2017
On August 16, 2017, the FDA designated MDMA-assisted psychotherapy for PTSD as a Breakthrough Therapy.
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Nov 30, 2017
Today is my 64th birthday! What a great time to be alive—we’re witnessing the revival of psychedelic research, the turning of the tide for marijuana prohibition, and MDMA is on the way to becoming a legal prescription medicine.
Rick Doblin, Ph.D., of MAPS
@RickDoblin
Apr 6, 2016
I’m speaking on the @JoeRogan Experience podcast on April 7 to talk about the current state of @MAPS' psychedelic research program!